Nippon India Pharma Fund vs Tata India Pharma & Healthcare Fund compare
Nippon India Pharma Fund-Growth Plan-Growth Option
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Chart Comparison
Overview
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹8357 Cr | ₹1309 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹500 | ₹100 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 05 Jun 2004 | 28 Dec 2015 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare | Nifty Pharma TRI |
Turn Over | 21% | 26.49% |
Expense Ratio | 1.82 | 2.14 |
Manager | Sailesh Raj Bhan | Meeta Shetty |
ISIN Code | INF204K01968 | INF277K016A9 |
Exits Load | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
1 Month | 2.03% | 1.07% |
6 Month | 11.71% | 12.87% |
1 Year | -1.63% | -1.47% |
3 Year | 22.87% | 23.49% |
5 Year | 19.06% | 19.42% |
SIP Return Analysis
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
6 Month | 2.85% | 3.9% |
1 Year | 8% | 9.27% |
3 Year | 21.14% | 22.51% |
5 Year | 18.27% | 19.09% |
Rolling Lumpsum Returns
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
1 Year | 17.31% | 10.55% |
3 Year | 20.52% | 18.34% |
5 Year | 20.64% | 15.18% |
Risk Management
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Standard Deviation | 15.03% | 15.94% |
Sharp | 1.00% | 0.99% |
Beta | 0.91% | 0.98% |
Alpha | 0.32% | -0.12% |
Fund Managers
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Name | Sailesh Raj Bhan | Meeta Shetty |
Total AUM | ₹96086 Cr | ₹17847 Cr |
Funds Managed | 5 | 5 |
Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Market Cap
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Others | 1.47 | 8.59 |
Large Cap | 34.68 | 27.92 |
Mid Cap | 32.06 | 32.96 |
Small Cap | 31.79 | 30.52 |
Sector Allocation
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Others | 0.55 | 6.22 |
Healthcare | 99.45 | 91.69 |
Basic Materials | - | 0.46 |
Financial Services | - | 1.63 |
Top Comparisons
SUNDARAM MEDIUM DURATION FUND Regular Plan - Growth
3Y Returns5.62%
HSBC Medium Duration Fund - Regular Growth
3Y Returns7.59%
Bandhan ELSS Tax saver Fund - Regular Plan - Growth
3Y Returns14.73%
UTI ELSS Tax Saver Fund - Regular Plan - Growth Option
3Y Returns11.76%
Aditya Birla Sun Life Floating Rate Fund-Regular Plan-Growth
3Y Returns7.61%
Aditya Birla Sun Life Floating Rate Fund-Regular Plan-Growth
3Y Returns7.61%
LIC MF Infrastructure Fund-Growth
3Y Returns26.12%
LIC MF Infrastructure Fund-Regular Plan-Growth
3Y Returns26.12%